No evidence that amifostine influences the plasma pharmacokinetics of topotecan in ovarian cancer patients

Verfasser / Beitragende:
[Anna-Lena Zackrisson, Henric Malmström, Curt Peterson]
Ort, Verlag, Jahr:
2002
Enthalten in:
European Journal of Clinical Pharmacology, 58/2(2002-05-01), 103-108
Format:
Artikel (online)
ID: 471045152